Journal of Vascular Surgery
Volume 39, Issue 1 , Pages 44-50 , January 2004

Focused screening for occult carotid artery disease: patients with known heart disease are at high risk

Presented at the Fifty-seventh Annual Meeting of the Society for Vascular Surgery, Chicago, Ill, June 8-11, 2003.

Received 11 June 2003 ,Accepted 31 July 2003.

References 

  1. American Heart Association. 2002 Heart and stroke statistical update. Dallas: The Association; 2001
  2. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 1999;282:2019-26
  3. Weinberger J. Prevention of ischemic stroke. Curr Cardiol Rep. 2002;4:164–171
  4. Hart RG, Bailey RD. An assessment of guidelines for prevention of ischemic stroke. Neurology. 2002;59:977–982
  5. Axelrod DA, Diwan A, Stanley JC, et al.  Cost of routine screening for carotid and lower extremity occlusive disease in patients with abdominal aortic aneurysms. J Vasc Surg. 2002;35:754–758
  6. Benade MM, Warlow CP. Cost of identifying patients for carotid endarterectomy. Stroke. 2002;33:435–439
  7. Cronenwett JL, Birkmeyer JD, Nackman GB, Fillinger MF, Bech FR, Zwolak RM, et al. Cost-effectiveness of carotid endarterectomy in asymptomatic patients. J Vasc Surg. 1997;25:298–309
  8. Derdeyn CP, Powers WJ. Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease. Stroke. 1996;27:1944–1950
  9. Holloway RG, Benesch CT, Rahilly CR, Courtright CE. A systematic review of cost-effectiveness research of stroke evaluation and treatment. Stroke. 1999;30:1340–1349
  10. Kuntz KM, Kent KC. Is carotid endarterectomy cost-effective?. an analysis of symptomatic and asymptomatic patients. Circulation. 1996;94:194–198
  11. Lee TT, Solomon NA, Heidenreich PA, Oehlert J, Garber AM. Cost-effectiveness of screening for carotid stenosis in asymptomatic persons. Ann Intern Med. 1997;126:657–658
  12. Yin D, Carpenter JP. Cost-effectiveness of screening for asymptomatic carotid stenosis. J Vasc Surg. 1998;27:245–255
  13. Zwolak RM. Coding and billing issues in the vascular laboratory. Semin Vasc Surg. 2001;14:160–168
  14. Lavenson GS. A new accurate, rapid and cost-effective protocol for stroke-prevention screening. Cardiovasc Surg. 1998;6:590–593
  15. Carsten CG, Elmore JR, Franklin DP, Thomas DD, Mordan F, Wood GC. Use of limited color-flow duplex for a carotid-screening project. Am J Surg. 1999;178:174–177
  16. Jacobowitz GR, Rockman CB, Gagne PJ, Adelman MA, Lamparello PJ, Landis R, et al. A model for predicting occult carotid artery disease: screening is justified in a selected population. J Vasc Surg 2003;38:705-9
  17. Fine-Edelstein JS, Wolf PA, O'Leary DH, et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology 1994;44:1046-50
  18. Mathiesen EB, Joakimsen O, Bonaa KH. Prevalence of and risk factors associated with carotid artery stenosis (the Tromso Study). Cerebrovasc Dis. 2001;12:44–51
  19. Bogousslavsky J, Regli F, Van Melle G. Risk factors and concomitants of internal carotid artery occlusion or stenosis (a controlled study of 159 cases). Arch Neurol. 1985;42:864–867
  20. Lernfelt B, Forsberg M, Blomstrand C, Mellstrom D, Volkmann R. Cerebral atherosclerosis as predictor of stroke and mortality in representative elderly population. Stroke. 2002;33:224–229
  21. Simos PCG, Algra A, Eikelboom BC, Grobbee DE, van der Graaf Y  for the SMART study group . Carotid artery stenosis in patients with peripheral arterial disease (The SMART study). J Vasc Surg. 1999;30:519–525
  22. Cheng SW, Wu LL, Ting AC, Lau H, Wong J. Screening for asymptomatic carotid stenosis in patients with peripheral vascular disease (a prospective study and risk factor analysis). Cardiovasc Surg. 1999;7:303–309
  23. Archbold RA, Barakat K, Magee P, Curzen N. Screening for carotid artery disease before cardiac surgery (is current clinical practice evidence based?). Clin Cardiol. 2001;24:26–32
  24. Ascher E, Hingorani A, Yorkovich W, Ramsey PJ, Salles-Cunha S. Routine preoperative carotid duplex scanning in patients undergoing open-heart surgery (is it worthwhile?). Ann Vasc Surg. 2001;15:669–678
  25. Ascher E, DePippo P, Salles-Cunha S, Marchese J, Yorkovich W. Carotid screening with duplex ultrasound in elderly asymptomatic patients referred to a vascular surgeon (is it worthwhile?). Ann Vasc Surg. 1999;13:164–168
  26. de Virgilio C, Toosie K, Arnell T, et al.  Asymptomatic carotid artery stenosis screening in patients with lower extremity atherosclerosis (a prospective study). Ann Vasc Surg. 1997;11:374–377
  27. Ahn SS, Baker JD, Walden K, Moore WS. Which asymptomatic patients should undergo routine screening carotid duplex scan?. Am J Surg. 1991;162:180–183
  28. Marek J, Mills JL, Harvich J, Cui H, Fujitani RM. Utility of routine carotid duplex screening in patients who have claudication. J Vasc Surg. 1996;24:572–577
  29. Kurvers HaH, van der Graaf Y, Blankensteijn JdJ, Visseren FLF, Eikelboom BcB. Screening for asymptomatic internal carotid artery stenosis and aneurysm of the abdominal aorta (comparing the yield between patients with manifest atherosclerosis and patients with risk factors for atherosclerosis only). J Vasc Surg. 2003;37:1226–1233
  30. Whitty CJM, Sudlow CLM, Warlow CP. Investigating individual subjects and screening populations for asymptomatic carotid stenosis can be harmful. Neurol Neurosurg Psychiatry. 1998;64:619–623
  31. North American Symptomatic Carotid Endarterectomy Trial Collaborators . Beneficial effects of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med. 1991;325:445–453
  32. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study . Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421–1428
  33. Baker JD. Costs of duplex scanning and the impact of the changes in Medicare reimbursement. J Vasc Surg. 1993;18:702–707
  34. Passman MA, Guzman RJ, Pierce R, Naslund TC. Impact of Medicare denials on noninvasive vascular diagnostic testing. J Vasc Surg. 2001;34:846–853
  35. Rockman CB, Riles TS, Lamparello PJ, et al.  Natural history and management of the asymptomatic, moderately stenotic internal carotid artery. J Vasc Surg. 1997;25:423–431
  36. Muluk SC, Muluk VS, Sugimoto H, et al.  Progression of asymptomatic carotid stenosis (a natural history study in 1004 patients). J Vasc Surg. 1999;29:208–214
  37. Qureshi AI, Janardhan V, Bennett SE, Luft AR, Hopkins LN, Guterman LR. Who should be screened for asymptomatic carotid artery stenosis?. experience from the Western New York Stroke Screening Program. J Neuroimaging. 2001;11:105–111

☆ Competition of interest: none.

PII: S0741-5214(03)01105-4

doi: 10.1016/j.jvs.2003.07.008

Journal of Vascular Surgery
Volume 39, Issue 1 , Pages 44-50 , January 2004

Article Tools

* Image Usage & Resolution